Market Overview

Benzinga's Top Pre-Market Losers

Share:
Related JCP
Top 4 NYSE Stocks In The Department Stores Industry With The Highest EPS Growth Forecast For Next Year
Here's Who Benefits The Most If Sears Goes Bankrupt
Is Archer Daniels (ADM) Poised for an Earnings Beat in Q4? - Analyst Blog (Zacks)
Related NKTR
Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2
What Investors Are Expecting Ahead Of Multiple Nektar Therapeutics Catalysts
Baxter (BAX) Beats Q4 Earnings Estimates, Sales Up Y/Y - Analyst Blog (Zacks)

Nektar Therapeutics (NASDAQ: NKTR) dipped 24.19% to $10.50 in the pre-market session after the company reported that the results from Phase 2 trial of NKTR-181 missed primary efficacy endpoint.

Zoltek Companies (NASDAQ: ZOLT) shares dropped 10.05% to $16.65 in pre-market trading after Toray Industries agreed to buy Zoltek Companies for $16.75 per share.

J. C. Penney Company (NYSE: JCP) shares fell 8.54% to $9.53 in the pre-market trading after the company priced its underwritten public offering of 84.0 million shares of its common stock at $9.65 per share.

Accenture (NYSE: ACN) dipped 4.18% to $72.70 in the pre-market session after the company reported a rise in its fiscal fourth-quarter net income. For the current fiscal year, the company projected net income of $4.42 to $4.54 per share, versus analysts' expectations of $4.50 per share.

Posted-In: Top Pre-Market LosersNews Movers & Shakers Pre-Market Outlook Markets

 

Related Articles (ACN + JCP)

Around the Web, We're Loving...

Get Benzinga's Newsletters